1.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PTH-302, NCT00080080
|
|
2.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PTH-301, NCT00083239
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PTH-303, NCT00083252
|
|
4.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PTH-203, FD-R-003021-01, NCT00086203
|
|
5.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 2 to 18 Sponsor: NCI, NIH WGMCC Protocol IDs: 050239, 05-C-0239, NCI-P6672, CDR0000462620, NCI-05-C-0239, NCT00303940
|